Andersen Tawil syndrome: genes and variants

Explore variant evidence for Andersen Tawil syndrome across 1 analyzed protein (KCNJ2). Linked ClinVar records include 34 pathogenic or likely pathogenic variants, 166 variants of uncertain significance and 25 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-10-15. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Andersen Tawil syndrome

Where Andersen Tawil syndrome variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Andersen Tawil syndrome

VariantPositionProtein partClinical label
KCNJ2 R82Q82TransmembranePathogenic / likely pathogenic (★★)
KCNJ2 R82W82TransmembranePathogenic / likely pathogenic (★★)
KCNJ2 G144S144Pore-formingPathogenic / likely pathogenic (★★)
KCNJ2 R312H312CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 R312C312CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 G144A144Pore-formingPathogenic / likely pathogenic (★★)
KCNJ2 G144D144Pore-formingPathogenic / likely pathogenic (★★)
KCNJ2 R218W218CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 R218P218CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 R218Q218CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 G146S146Pore-formingPathogenic / likely pathogenic (★★)
KCNJ2 R189G189Polyphosphoinositide (PIP2)-bindingPathogenic / likely pathogenic (★★)
KCNJ2 G300V300CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 R67Q67CytoplasmicPathogenic / likely pathogenic (★★)
KCNJ2 T75K75CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 T75R75CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 D78Y78CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 D78N78CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 P186Q186Polyphosphoinositide (PIP2)-bindingPathogenic / likely pathogenic (★)
KCNJ2 T305A305CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 T309I309CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 Y145C145Pore-formingPathogenic / likely pathogenic (★)
KCNJ2 G215D215CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 N216Y216CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 E299G299CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 R260H260CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 C54F54CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 D71V71CytoplasmicPathogenic / likely pathogenic (★)
KCNJ2 L90R90TransmembranePathogenic / likely pathogenic (★)
KCNJ2 D172N172TransmembranePathogenic / likely pathogenic (★)
KCNJ2 T192A192Polyphosphoinositide (PIP2)-bindingPathogenic / likely pathogenic (★)
KCNJ2 P186L186Polyphosphoinositide (PIP2)-bindingPathogenic / likely pathogenic
KCNJ2 T305P305CytoplasmicPathogenic / likely pathogenic
KCNJ2 V302M302CytoplasmicPathogenic / likely pathogenic

Uncertain variants prioritized for review in Andersen Tawil syndrome

VariantPositionProtein partClinical labelEvidence
KCNJ2 G144V144Pore-formingConflicting reports (★)+6: 5 other pathogenic changes within 3 positions; G144A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
KCNJ2 T192I192Polyphosphoinositide (PIP2)-bindingConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; T192A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
KCNJ2 R218L218CytoplasmicConflicting reports (★)+6: 5 other pathogenic changes within 3 positions; R218W at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
KCNJ2 R189K189Polyphosphoinositide (PIP2)-bindingConflicting reports (★)+6: 4 other pathogenic changes within 3 positions; R189G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99
KCNJ2 G215C215CytoplasmicUncertain (★)+6: 5 other pathogenic changes within 3 positions; G215D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98
KCNJ2 G146D146Pore-formingUncertain (★)+6: 5 other pathogenic changes within 3 positions; G146S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
KCNJ2 D78H78CytoplasmicUncertain (★)+6: 4 other pathogenic changes within 3 positions; D78Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00
KCNJ2 N216I216CytoplasmicUncertain (★)+6: 5 other pathogenic changes within 3 positions; N216Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99
KCNJ2 R189T189Polyphosphoinositide (PIP2)-bindingUncertain (★)+6: 4 other pathogenic changes within 3 positions; R189G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00

Diseases related to Andersen Tawil syndrome

Frequently asked questions

Which genes have records linked to Andersen Tawil syndrome?

This view contains 1 analyzed proteins: KCNJ2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 34 pathogenic or likely pathogenic variants, 166 variants of uncertain significance and 25 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 9 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 240 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center